Project AFECT (Autism Family Empowerment Coaching and Training Program)

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05910502
Collaborator
California Department of Developmental Services (Other)
120
2
2
37
60
1.6

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to learn about the journey of families after their child's diagnosis of autism and to help parents understand autism and get the right treatments for their child. This study is for parents of children just diagnosed with autism who are:

  • Age greater than 1 and up to 5 years old;

  • Hispanic/Latino OR Black/African-American OR have Medi-Cal as primary health insurance; AND

  • Live in one of the following counties in California (Alameda, Contra Costa, Marin, Monterey, Napa, San Benito, San Francisco, San Mateo, Santa Clara, Santa Cruz, Solano, or Sonoma).

The main questions it aims to answer are:
  • Whether parent coaching through Project AFECT leads to decreased parental stress and increased parental confidence;

  • Whether family navigation through Project AFECT leads to increased number of referrals to early intervention and educational services and reduced wait times to autism treatments;

  • Whether children whose parents receive Project AFECT intervention show increased language skills compared to children whose parents did not receive intervention.

Participants will be asked to:
  • Complete surveys at enrollment and 3 and 6 months later.

  • Work with Project AFECT Coach.

Researchers will compare control and intervention groups to see if Project AFECT leads to improved parent and child outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Autism Family Empowerment Coaching and Training Program
N/A

Detailed Description

This is a prospective clinical effectiveness study of Project AFECT, an intervention combining parent coaching and family navigation. Parents who meet inclusion criteria will be invited to participate in this study at the time of their child's autism diagnosis at Stanford Medicine Children's Health.

Participants in the control group will receive treatment as usual. In addition to treatment as usual, participants in the intervention group will be connected with Project AFECT Coaches who will provide: Coaching to (1) assure parents understand diagnosis, (2) assist parents in finding accurate, current information about autism, (3) guide parents to free online autism training resources, (4) empower parents to evaluate child's intervention plan holistically, and (5) provide emotional support to reduce stress; Navigation to (1) help family access autism treatments, and (2) connect to early intervention and educational services.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Waitlist control Participants in the control group will be offered the opportunity to participate in the intervention group if the child has not received any autism treatments 6 months after enrollment in this study.Waitlist control Participants in the control group will be offered the opportunity to participate in the intervention group if the child has not received any autism treatments 6 months after enrollment in this study.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Autism Family Empowerment Coaching and Training Program (AFECT): Evaluating a Parent Coaching and Family Navigation Program for New Autism Spectrum Disorder Diagnosis
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2025
Anticipated Study Completion Date :
Jun 30, 2026

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Treatment As Usual Group

This group will receive treatment as usual.

Experimental: Coaching Group

Coaching Group will receive Project AFECT intervention, in addition to treatment as usual.

Behavioral: Autism Family Empowerment Coaching and Training Program
Participants in the intervention group will be connected with Project AFECT Coaches who will provide: Coaching to (1) assure parents understand diagnosis, (2) assist parents in finding accurate, current information about autism, (3) guide parents to free online autism training resources, (4) empower parents to evaluate child's intervention plan holistically, and (5) provide emotional support to reduce stress; Navigation to (1) help family access autism treatments, and (2) connect to early intervention and educational services.
Other Names:
  • Project AFECT
  • Outcome Measures

    Primary Outcome Measures

    1. Self-Efficacy [From enrollment to the end of intervention at 6 months]

      Mean change from baseline in parental self-efficacy measured using Autism-Specific Parenting Self-Efficacy Scale (PSEaS). Overall possible scores on the scale range from 17 - 85. The higher the score, the higher the measured level of parental self-efficacy (better outcome).

    2. Stress Level [From enrollment to the end of intervention at 6 months]

      Mean change from baseline in parental stress level measured using Parental Stress Scale (PSS). Overall possible scores on the scale range from 18 - 90. The higher the score, the higher the measured level of parental stress (worse outcome).

    Secondary Outcome Measures

    1. Child's Language Development [From enrollment to the end of intervention at 6 months]

      Scores using MacArthur-Bates Communicative Development Inventory - Words and Gestures. For comparison between groups, we will be utilizing the raw scores. Overall possible raw scores range from 0 - 396. The higher the raw score, the higher the number of words understood and produced by the child (better outcome).

    2. Wait time to autism treatments [From enrollment to the end of intervention at 6 months]

      Time from initial autism diagnosis to start of applied behavior analysis (ABA) therapy

    3. Wait time to early intervention/special education [From enrollment to the end of intervention at 6 months]

      Time from initial autism diagnosis to assessment for early intervention/special education and development of Individualized Family Service Plan (IFSP)/Individualized Education Program (IEP)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Months to 60 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Parents of children just diagnosed with autism (with or without other diagnoses) who are:

    2. Age greater than 1 and up to 5 years old;

    3. Hispanic/Latino OR Black/African-American OR have Medi-Cal as primary health insurance; AND

    4. Live in one of the following counties in California (Alameda, Contra Costa, Marin, Monterey, Napa, San Benito, San Francisco, San Mateo, Santa Clara, Santa Cruz, Solano, or Sonoma).

    Exclusion Criteria:
    • Non-legal guardians or foster parents who provide care to children newly diagnosed with autism.

    • Parents of children without diagnosis of autism.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Gardner Packard Children's Health Center Atherton California United States 94027
    2 Stanford Medicine Children's Health Sunnyvale California United States 94087

    Sponsors and Collaborators

    • Stanford University
    • California Department of Developmental Services

    Investigators

    • Principal Investigator: Heidi Feldman, MD, PhD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Heidi M. Feldman, Professor of Developmental and Behavioral Pediatrics, Stanford University School of Medicine, Stanford University
    ClinicalTrials.gov Identifier:
    NCT05910502
    Other Study ID Numbers:
    • IRB#69103
    First Posted:
    Jun 18, 2023
    Last Update Posted:
    Jun 27, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Heidi M. Feldman, Professor of Developmental and Behavioral Pediatrics, Stanford University School of Medicine, Stanford University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 27, 2023